For the first time worldwide, researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against plague bacteria, lethal to humans. It also works against antibiotic resistant bacteria. https://english.tau.ac.il/mrna_vaccine … Continue reading →

For 6 years Tel Aviv University scientists have studied how certain viruses (bacteriophages) take control of dangerous antibiotic resistant bacteria (see here). They found that a virus protein uses a DNA-repair protein in the bacteria to “cunningly” cut the bacteria’s … Continue reading →

I reported previously (May 2017) on one Israeli biotech using the human microbiome (stomach bacteria) to fight cancer, IBD, acne etc. Now Israel’s Evogene’s new Biomica subsidiary is also developing microbiome therapies, for antibiotic resistant bacteria, immuno-oncology and GI disorders. … Continue reading →

Researchers at Israel’s Technion Institute have discovered unique amyloid fibrils used by the deadly antibiotic resistant MRSA bacteria to attack the immune system. It means treatments that inhibit the amyloid formation will neutralize MRSA. http://www.technion.ac.il/en/2017/02/staphylococcus-aureus-bacteria/

The UN has prioritized fighting antibiotic resistance. Meanwhile, the European Commission has granted 2.3 million Euros to Israeli biotech MeMed to help develop its fast blood test that distinguishes between bacterial and viral infections – and thus significantly reduces the … Continue reading →

A joint team of scientists at the Hebrew University of Jerusalem and from the Netherlands have discovered that the common E. coli bacteria plays “hide and seek” to avoid detection from the predatory B. bacteriovorus bacteria. It extends research into … Continue reading →

Israel’s MeMed Diagnostics (see here previously) has received US FDA clearance for its MeMed BV blood test that can distinguish, in minutes, between bacterial and viral infections. It can help prevent the inappropriate use of antibiotics that leads to antimicrobial … Continue reading →

Researchers from Israel’s Ben-Gurion University and elsewhere have developed “molecular tweezers” to combat antibiotic-resistant bacteria. The tweezers destroy the biofilm that protects the bacteria against the immune system. Bacteria cannot develop resistance to this method of attack. https://americansforbgu.org/bgu-molecular-tweezers-battle-bacteria/ https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(21)00152-5

Arab-Israeli Professor Ashraf Brik (see here previously) of Israel’s Technion and his team have overcome a 60-year technical problem to synthesize plectasin, a peptide with promising antibiotic results against multi-resistant bacteria, and linaclotide, to treat irritable bowel syndrome. https://www.technion.ac.il/en/2021/02/six-decades-old-protein-synthesis-problem-solved-at-technion/ https://www.nature.com/articles/s41467-021-21209-0